Cargando…

Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model

Humanized mice are emerging as an alternative model system to well-established non-human primate (NHP) models for studying human immunodeficiency virus (HIV)-1 biology and pathogenesis. Although both NHP and humanized mice have their own strengths and could never truly reflect the complex human immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jiae, Peachman, Kristina K., Jobe, Ousman, Morrison, Elaine B., Allam, Atef, Jagodzinski, Linda, Casares, Sofia A., Rao, Mangala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663722/
https://www.ncbi.nlm.nih.gov/pubmed/29163484
http://dx.doi.org/10.3389/fimmu.2017.01405
_version_ 1783274866365956096
author Kim, Jiae
Peachman, Kristina K.
Jobe, Ousman
Morrison, Elaine B.
Allam, Atef
Jagodzinski, Linda
Casares, Sofia A.
Rao, Mangala
author_facet Kim, Jiae
Peachman, Kristina K.
Jobe, Ousman
Morrison, Elaine B.
Allam, Atef
Jagodzinski, Linda
Casares, Sofia A.
Rao, Mangala
author_sort Kim, Jiae
collection PubMed
description Humanized mice are emerging as an alternative model system to well-established non-human primate (NHP) models for studying human immunodeficiency virus (HIV)-1 biology and pathogenesis. Although both NHP and humanized mice have their own strengths and could never truly reflect the complex human immune system and biology, there are several advantages of using the humanized mice in terms of using primary HIV-1 for infection instead of simian immunodeficiency virus or chimera simian/HIV. Several different types of humanized mice have been developed with varying levels of reconstitution of human CD45(+) cells. In this study, we utilized humanized Rag1KO.IL2RγcKO.NOD mice expressing HLA class II (DR4) molecule (DRAG mice) infused with HLA-matched hematopoietic stem cells from umbilical cord blood to study early events after HIV-1 infection, since the mucosal tissues of these mice are highly enriched for human lymphocytes and express the receptors and coreceptors needed for HIV-1 entry. We examined the various tissues on days 4, 7, 14, and 21 after an intravaginal administration of a single dose of purified primary HIV-1. Plasma HIV-1 RNA was detected as early as day 7, with 100% of the animals becoming plasma RNA positive by day 21 post-infection. Single cells were isolated from lymph nodes, bone marrow, spleen, gut, female reproductive tissue, and brain and analyzed for gag RNA and strong stop DNA by quantitative (RT)-PCR. Our data demonstrated the presence of HIV-1 viral RNA and DNA in all of the tissues examined and that the virus was replication competent and spread rapidly. Bone marrow, gut, and lymph nodes were viral RNA positive by day 4 post-infection, while other tissues and plasma became positive typically between 7 and 14 days post-infection. Interestingly, the brain was the last tissue to become HIV-1 viral RNA and DNA positive by day 21 post-infection. These data support the notion that humanized DRAG mice could serve as an excellent model for studying the trafficking of HIV-1 to the various tissues, identification of cells harboring the virus, and thus could serve as a model system for HIV-1 pathogenesis and reservoir studies.
format Online
Article
Text
id pubmed-5663722
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56637222017-11-21 Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model Kim, Jiae Peachman, Kristina K. Jobe, Ousman Morrison, Elaine B. Allam, Atef Jagodzinski, Linda Casares, Sofia A. Rao, Mangala Front Immunol Immunology Humanized mice are emerging as an alternative model system to well-established non-human primate (NHP) models for studying human immunodeficiency virus (HIV)-1 biology and pathogenesis. Although both NHP and humanized mice have their own strengths and could never truly reflect the complex human immune system and biology, there are several advantages of using the humanized mice in terms of using primary HIV-1 for infection instead of simian immunodeficiency virus or chimera simian/HIV. Several different types of humanized mice have been developed with varying levels of reconstitution of human CD45(+) cells. In this study, we utilized humanized Rag1KO.IL2RγcKO.NOD mice expressing HLA class II (DR4) molecule (DRAG mice) infused with HLA-matched hematopoietic stem cells from umbilical cord blood to study early events after HIV-1 infection, since the mucosal tissues of these mice are highly enriched for human lymphocytes and express the receptors and coreceptors needed for HIV-1 entry. We examined the various tissues on days 4, 7, 14, and 21 after an intravaginal administration of a single dose of purified primary HIV-1. Plasma HIV-1 RNA was detected as early as day 7, with 100% of the animals becoming plasma RNA positive by day 21 post-infection. Single cells were isolated from lymph nodes, bone marrow, spleen, gut, female reproductive tissue, and brain and analyzed for gag RNA and strong stop DNA by quantitative (RT)-PCR. Our data demonstrated the presence of HIV-1 viral RNA and DNA in all of the tissues examined and that the virus was replication competent and spread rapidly. Bone marrow, gut, and lymph nodes were viral RNA positive by day 4 post-infection, while other tissues and plasma became positive typically between 7 and 14 days post-infection. Interestingly, the brain was the last tissue to become HIV-1 viral RNA and DNA positive by day 21 post-infection. These data support the notion that humanized DRAG mice could serve as an excellent model for studying the trafficking of HIV-1 to the various tissues, identification of cells harboring the virus, and thus could serve as a model system for HIV-1 pathogenesis and reservoir studies. Frontiers Media S.A. 2017-10-27 /pmc/articles/PMC5663722/ /pubmed/29163484 http://dx.doi.org/10.3389/fimmu.2017.01405 Text en Copyright © 2017 Kim, Peachman, Jobe, Morrison, Allam, Jagodzinski, Casares and Rao. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Kim, Jiae
Peachman, Kristina K.
Jobe, Ousman
Morrison, Elaine B.
Allam, Atef
Jagodzinski, Linda
Casares, Sofia A.
Rao, Mangala
Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title_full Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title_fullStr Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title_full_unstemmed Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title_short Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
title_sort tracking human immunodeficiency virus-1 infection in the humanized drag mouse model
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663722/
https://www.ncbi.nlm.nih.gov/pubmed/29163484
http://dx.doi.org/10.3389/fimmu.2017.01405
work_keys_str_mv AT kimjiae trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT peachmankristinak trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT jobeousman trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT morrisonelaineb trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT allamatef trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT jagodzinskilinda trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT casaressofiaa trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel
AT raomangala trackinghumanimmunodeficiencyvirus1infectioninthehumanizeddragmousemodel